Curcumin inhibits protease-activated receptor-2 and -4-mediated mast cell activation

Clinica Chimica Acta

Volumn 338, Issue 1-2, 2003, Pages 135-141

  Baek, Ok Seon ^a,b   Kang, Ok Hwa ^a   Choi, Yeon A ^a   Choi, Suck Chei ^c   Kim, Tae Hyun ^c   Nah, Yong Ho ^c   Kwon, Dong Yeul ^a   Kim, Yun Kyung ^a   Kim, Young Ho ^d   Bae, Ki Hwan ^d   Lim, Jong Pil ^b   Lee, Young Mi ^a  

^a Wonkwang University   (South Korea)

^b Woosuk University   (South Korea)

^c Wonkwang University School of Medicine   (South Korea)

^d Chungnam National University   (South Korea)

Author keywords

Curcumin; MAPK; Protease activated receptor; TNF ; Trypsin; Tryptase

Indexed keywords

AMIDE; CURCUMIN; GLYCYLTYROSYLPROLYLGLYCYLGLUTAMYLVALINAMIDE; MITOGEN ACTIVATED PROTEIN KINASE; PEPTIDE DERIVATIVE; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE ACTIVATED RECEPTOR 4; SERYLLEUCYLGLYCYLLYSYLVALINAMIDE; TRYPSIN; TRYPTASE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MAST CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

CURCUMA; CURCUMA LONGA;

EID: 10744233392     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2003.08.015     Document Type: Article

References (27)

1. Goel A., Boland C.R., Chauhan D.P. Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells. Cancer Lett. 172:2001;111-118.
2. Pan M.H., Lin-Shiau S.Y., Lin J.K. Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down-regulation of IkappaB kinase and NFkappaB activation in macrophages. Biochem. Pharmacol. 60:2000;1665-1676.
3. Kumar A., Dhawan S., Hardegen N.J., Aggarwal B.B. Curcumin (Diferuloylmethane) inhibition of tumor necrosis factor (TNF)-mediated adhesion of monocytes to endothelial cells by suppression of cell surface expression of adhesion molecules and of nuclear factor-kappaB activation. Biochem. Pharmacol. 55:1998;775-783.
4. Sugimoto K., Hanai H., Tozawa K., Aoshi T., Uchijima M., Nagata T.et al. Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice. Gastroenterology. 123:2002;1912-1922.
5. Metcalfe D.D., Baram D., Mekori Y.A. Mast cells. Physiol. Rev. 77:1997;1033-1079.
6. Stoyanova I.I., Gulubova M.V. Mast cells and inflammatory mediators in chronic ulcerative colitis. Acta Histochem. 104:2002;185-192.
7. Macfarlane S.R., Seatter M.J., Kanke T., Hunter G.D., Plevin R. Proteinase-activated receptors. Pharmacol. Rev. 53:2001;245-282.
8. Bohm S.K., Kong W., Bromme D., Smeekens S.P., Anderson D.C., Connolly A.et al. Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2. Biochem. J. 314:1996;1009-1016.
9. Nystedt S., Emilsson K., Larsson A.K., Strombeck B., Sundelin J. Molecular cloning and functional expression of the gene encoding the human proteinase-activated receptor 2. Eur. J. Biochem. 232:1995;84-89.
10. Xu W.F., Andersen H., Whitmore T.E., Presnell S.R., Yee D.P., Ching A.et al. Cloning and characterization of human protease-activated receptor 4. Proc. Natl. Acad. Sci. U. S. A. 95:1998;6642-6646.
11. Ferazzini MA, Santi S, Macnaughton WK, Hollenberg MD, Wallace JL, Vergnolle N. Proteinase-activated receptor-4 is implicated in the pathogenesis of Dextran Sodium Sulfate colitis. Digestive Disease Week 2003; Publishing ID: T1113, Abstract ID: 107259.
12. Kang O.H., Jeong H.J., Kim D.K., Choi S.C., Kim T.H., Nah Y.H.et al. Trypsin induces tumour necrosis factor-alpha secretion from a human leukemic mast cell line. Cell Biochem. Funct. 21:2003;161-167.
13. Lundberg A.H., Eubanks J.W. III, Henry J., Sabek O., Kotb M., Gaber L.et al. Trypsin stimulates production of cytokines from peritoneal macrophages in vitro and in vivo. Pancreas. 21:2000;41-51.
14. Kawabata A., Kuroda R., Minami T., Kataoka K., Taneda M. Increased vascular permeability by a specific agonist of protease-activated receptor-2 in rat hindpaw. Br. J. Pharmacol. 125:1998;419-422.
15. Lindner J.R., Kahn M.L., Coughlin S.R., Sambrano G.R., Schauble E., Bernstein D.et al. Delayed onset of inflammation in protease-activated receptor-2-deficient mice. J. Immunol. 165:2000;6504-6510.
16. Cenac N., Coelho A.M., Nguyen C., Compton S., Andrade-Gordon P., MacNaughton W.K.et al. Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2. Am. J. Pathol. 161:2002;1903-1915.
17. Vanderslice P., Ballinger S.M., Tam E.K., Goldstein S.M., Craik C.S., Caughey G.H. Human mast cell tryptase: multiple cDNAs and genes reveal a multigene serine protease family. Proc. Natl. Acad. Sci. U. S. A. 87:1990;3811-3815.
18. Lee Y.B., Schrader J.W., Kim S.U. P38 map kinase regulates TNF-alpha production in human astrocytes and microglia by multiple mechanisms. Cytokine. 12:2000;874-880.
19. Smith T.J., Hougland M.W., Johnson D.A. Human lung tryptase. Purification and characterization. J. Biol. Chem. 259(17):1984;11046-11051.
20. Raithel M., Winterkamp S., Pacurar A., Ulrich P., Hochberger J., Hahn E.G. Release of mast cell tryptase from human colorectal mucosa in inflammatory bowel disease. Scand. J. Gastroenterol. 36:2001;174-179.
21. Kim J.A., Choi S.C., Yun K.J., Kim D.K., Han M.K., Seo G.S.et al. Expression of protease-activated receptor 2 in ulcerative colitis. Inflamm. Bowel Dis. 9:2003;224-229.
22. Araki Y., Andoh A., Fujiyama Y., Bamba T. Development of dextran sulphate sodium-induced experimental colitis is suppressed in genetically mast cell-deficient Ws/Ws rats. Clin. Exp. Immunol. 119:2000;264-269.
23. Gratz R., Becker S., Sokolowski N., Schumann M., Bass D., Malnick S.D. Murine monoclonal anti-TNF antibody administration has a beneficial effect on inflammatory bowel disease that develops in IL-10 knockout mice. Dig. Dis. Sci. 47:2002;1723-1727.
24. Tremaine W.J., Brzezinski A., Katz J.A., Wolf D.C., Fleming T.J., Mordenti J.et al. Treatment of mildly to moderately active ulcerative colitis with a tryptase inhibitor (APC 2059): an open-label pilot study. Aliment. Pharmacol. Ther. 16:2002;407-413.
25. Chen Y.R., Tan T.H. Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin. Oncogene. 17:1998;173-178.
26. Temkin V., Kantor B., Weg V., Hartman M.L., Levi-Schaffer F. Tryptase activates the mitogen-activated protein kinase/activator protein-1 pathway in human peripheral blood eosinophils, causing cytokine production and release. J. Immunol. 169:2002;2662-2669.
27. Ishizuka T., Terada N., Gerwins P., Hamelmann E., Oshiba A., Fanger G.R.et al. Mast cell tumor necrosis factor alpha production is regulated by MEK kinases. Proc. Natl. Acad. Sci. U. S. A. 94:1997;6358-6363.